Table 3 Comparison between patients with and without ICD behaviors (mean ± SD, n, %, p)

Number of case

208

9

Age, year

67.25 ± 8.82

63.67 ± 10.55

0. 469

Male, n(%)

114 (54.8 %)

6 (66.7 %)

0.521

Disease duration, year

5.76 ± 4.38

6.44 ± 3.17

0.33

Dose of levodopa, (mg/d)

425.0 ± 327.26

791.67 ± 802.73

0.066

DA - LED, (mg/d)

60.5 ± 80.5

119.4 ± 86.4

0.019*

TLED, (mg/d)

503.78 ± 359.13

912.81 ± 878.73

0.031*

H&Y stage

1.41 ± 0.52

2.33 ± 0.87

0.013*

Use of agonists, n(%)

94(45.2 %)

7 (77.8 %)

0.055